318 related articles for article (PubMed ID: 9115786)
1. Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines.
Roberts SJ; Bateman DN; Smith JM
Br J Gen Pract; 1997 Jan; 47(414):13-8. PubMed ID: 9115786
[TBL] [Abstract][Full Text] [Related]
2. Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications.
Martin A; Godman B; Miranda J; Tilstone J; Saleem N; Olsson E; Acosta A; Restrepo L; Bennie M
J Comp Eff Res; 2014 Jan; 3(1):41-51. PubMed ID: 24345256
[TBL] [Abstract][Full Text] [Related]
3. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients.
Stebbins MR; Frear ME; Cutler TW; Lightwood JM; Fingado AR; Lai CJ; Lipton HL
J Manag Care Pharm; 2013 Sep; 19(7):534-41. PubMed ID: 23964614
[TBL] [Abstract][Full Text] [Related]
4. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
[TBL] [Abstract][Full Text] [Related]
5. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
Prosser H; Walley T
Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
[TBL] [Abstract][Full Text] [Related]
6. New medicines in primary care: a review of influences on general practitioner prescribing.
Mason A
J Clin Pharm Ther; 2008 Feb; 33(1):1-10. PubMed ID: 18211610
[TBL] [Abstract][Full Text] [Related]
7. Medication prescribing advice and drug utilization: a review from the United Kingdom.
Law J; Thompson A
Pharm Pract Manag Q; 1996 Jan; 15(4):27-35. PubMed ID: 10153842
[TBL] [Abstract][Full Text] [Related]
8. Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios.
Conklin MH; Culley EJ; O'Donnell J
J Manag Care Pharm; 2009; 15(1):55-61. PubMed ID: 19125550
[TBL] [Abstract][Full Text] [Related]
9. A prescribing incentive scheme for non-fundholding general practices: an observational study.
Bateman DN; Campbell M; Donaldson LJ; Roberts SJ; Smith JM
BMJ; 1996 Aug; 313(7056):535-8. PubMed ID: 8789984
[TBL] [Abstract][Full Text] [Related]
10. Alterations in prescribing by general practitioner fundholders: an observational study.
Wilson RP; Buchan I; Walley T
BMJ; 1995 Nov; 311(7016):1347-50. PubMed ID: 7496289
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders.
Wilson RP; Hatcher J; Barton S; Walley T
Br J Gen Pract; 1999 Jun; 49(443):431-5. PubMed ID: 10562740
[TBL] [Abstract][Full Text] [Related]
12. The impact of a general practice group intervention on prescribing costs and patterns.
Walker J; Mathers N
Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
[TBL] [Abstract][Full Text] [Related]
13. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
14. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
[TBL] [Abstract][Full Text] [Related]
15. A comparison of three methods of setting prescribing budgets, using data derived from defined daily dose analyses of historic patterns of use.
Maxwell M; Howie JG; Pryde CJ
Br J Gen Pract; 1998 Aug; 48(433):1467-72. PubMed ID: 10024703
[TBL] [Abstract][Full Text] [Related]
16. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
[TBL] [Abstract][Full Text] [Related]
17. Generic and therapeutic substitutions in the UK: are they a good thing?
Duerden MG; Hughes DA
Br J Clin Pharmacol; 2010 Sep; 70(3):335-41. PubMed ID: 20716231
[TBL] [Abstract][Full Text] [Related]
18. Appropriate prescribing in asthma and its related cost in east London.
Naish J; Sturdy P; Toon P
BMJ; 1995 Jan; 310(6972):97-100. PubMed ID: 7833736
[TBL] [Abstract][Full Text] [Related]
19. Potential savings from generic prescribing and generic substitution in South Africa.
Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
[TBL] [Abstract][Full Text] [Related]
20. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.
Scott AB; Culley EJ; O'Donnell J
J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
